PARADIGM BIOPHARMACEUTICALS : Mount Sinai Partners With Paradigm Biopharmaceuticals Ltd., ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

Press/Media

Period18 Jan 2019 → 19 Jan 2019

Media coverage

3

Media coverage